The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.

The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.

<h4>Background</h4>The survival time of patients with early pancreatic cancer (PC) is still disappointing, even after surgical resection. PC has an extremely poor prognosis. Herein, we aimed to investigate the survival effect of postoperative radiotherapy (PORT) on resected stage I to II...

Full description

Bibliographic Details
Main Authors:	Zhuang-Bin Lin, Jian-Yuan Song, An-Chuan Li, Cheng Chen, Xiao-Xue Huang, Ben-Hua Xu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0243170

Similar Items

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study
by: Zhiju Chen, et al.
Published: (2020-12-01)

Effect of adjuvant radiotherapy treatment center volume on overall survival
by: Agrawal, A., et al.
Published: (2018)

Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
by: Alessio G. Morganti, et al.
Published: (2019-06-01)

Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients
by: Bayoumi Y, et al.
Published: (2014-11-01)

Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study
by: Jenny Ling-Yu Chen, et al.
Published: (2020-04-01)

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis
by: Wei-Ren Liu, et al.
Published: (2020-07-01)

A 25-gene classifier predicts overall survival in resectable pancreatic cancer
by: David J. Birnbaum, et al.
Published: (2017-09-01)

The Survival Benefits of Surgical Resection and Adjuvant Therapy for Patients With Brainstem Glioma
by: Zhuoyi Liu, et al.
Published: (2021-03-01)

Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis
by: Yaw-Sen Chen, et al.
Published: (2021-05-01)

Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
by: Chao Wu, et al.
Published: (2020-09-01)

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
by: Chih-Wen Lin, et al.
Published: (2020-04-01)

Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study
by: Dong Han, et al.
Published: (2021-05-01)

Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis
by: Wang L, et al.
Published: (2018-07-01)

Resection of unicentric interlobar Castleman disease with following adjuvant radiotherapy
by: Bruno Sarana, et al.
Published: (2017-11-01)

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
by: Run-Cong Nie, et al.
Published: (2020-05-01)

Potential Impact of on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score–Matched Analysis
by: Sung Hwan Lee MD, PhD, et al.
Published: (2019-02-01)

Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis
by: Zibo Meng, et al.
Published: (2019-04-01)

Could Preoperative Chemoradiotherapy Lead to the Survival Benefit of Patients with Resectable Pancreatic Cancer?
by: Yoon Suk Lee
Published: (2020-04-01)

Adjuvant Chemo-Radiotherapy versus Chemotherapy in Pancreatic Carcinoma
by: Shimaa Attia, et al.
Published: (2017-06-01)

Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer?
by: Elisabetta Fenocchio, et al.
Published: (2019-10-01)

Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis
by: Guoxing Wan, et al.
Published: (2018-09-01)

Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis
by: Pei-Yun Zhou, et al.
Published: (2017-11-01)

The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer
by: Adam Durczynski, et al.
Published: (2017-12-01)

Survival Impact of Postoperative Adjuvant Radiotherapy for Treatment of Advanced Stage Maxillary Sinus Cancer Patients
by: Upendra Nandwana, et al.
Published: (2018-02-01)

Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer
by: Di Li, et al.
Published: (2021-09-01)

Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma
by: Xiaoke Zhu, et al.
Published: (2020-05-01)

The Impact of Prolonged Chemotherapy to Surgery Interval and Neoadjuvant Radiotherapy on Pathological Complete Response and Overall Survival in Pancreatic Cancer Patients
by: Basem Azab, et al.
Published: (2020-07-01)

A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma
by: Li-xiang Zhang, et al.
Published: (2020-04-01)

Effect of the Extent of Resection on Survival Outcome in Glioblastoma: Propensity Score Approach
by: Thara Tunthanathip, et al.
Published: (2021-03-01)

Adjuvant radiotherapy for patients with pathologic node‐negative esophageal carcinoma: A population based propensity matching analysis
by: Hui‐Jiang Gao, et al.
Published: (2020-02-01)

Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
by: Xinyu Wang, et al.
Published: (2018-11-01)

Adjuvant External Beam Radiotherapy with Concurrent Cisplatin after Resection of Gallbladder Cancer
by: Sunil Choudhary, et al.
Published: (2019-02-01)

Impacts of post‐radiotherapy lymphocyte count on progression‐free and overall survival in patients with stage III lung cancer
by: Juliana Matiello, et al.
Published: (2020-11-01)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
by: Siddharth Iyengar, et al.
Published: (2021-09-01)

Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer
by: Chengdi Wang, et al.
Published: (2020-02-01)

Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis
by: Jian Li, et al.
Published: (2019-07-01)

The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis
by: Yoichi Miyata, et al.
Published: (2021-03-01)

Impact of Adjuvant Chemoradiotherapy on Survival of Resected Pancreatic Adenocarcinoma Cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis
by: Xiaomao Shi, et al.
Published: (2021-07-01)

The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma
by: Song T, et al.
Published: (2020-03-01)

Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy
by: Richard Fischer, et al.
Published: (2012-01-01)